Takayuki Ando

Homepage URL (1)： https://academist-cf.com/projects/259

Research field (1)： Pharmaceuticals - chemistry and drug development

Research keywords (1)： Medicinal Chemstry

Research theme for competitive and other funds (7)：

2022 - 2025 新規抗がん剤開発を目指すtRNA修飾酵素と阻害化合物の構造活性相関解明
2020 - 2023 膠芽腫幹細胞を標的としたtRNAメチル化酵素阻害剤による制がん戦略の構築
2020 - 2023 Innovative drug development targeting specific DNA repair pathway in cancer cells
2018 - 2022 Targeting ceramide synthase 6–dependent metastasis-prone phenotype in lung cancer cells
2018 - 2021 Identification of small molecular compounds with PD-1 / PD-L1 inhibitory activity by in silico

Show all

Papers (23)：

Tao Zhou, Takayuki Ando, Akihiro Kudo, Michio Sato, Noriyuki Miyoshi, Michihiro Mutoh, Hideki Ishikawa, Keiji Wakabayashi, Kenji Watanabe. Screening method toward ClbP-specific inhibitors. Genes and environment : the official journal of the Japanese Environmental Mutagen Society. 2023. 45. 1. 8-8
YASUTO AKIYAMA, TADASHI ASHIZAWA, AKIRA IIZUKA, TAKAYUKI ANDO, YOSHINOBU ISHIKAWA, RYOTA KONDOU, HARUO MIYATA, CHIE MAEDA, AKARI KANEMATSU, TAKASHI SUGINO, et al. Development of Novel Small Antitumor Compounds Inhibiting PD-1/PD-L1 Binding. Anticancer Research. 2022. 42. 11. 5233-5247
Akiko Tsuchida, Motohiro Senda, Akihiro Ito, Seiichi Saito, Makoto Kiso, Takayuki Ando, Anne Harduin-Lepers, Akio Matsuda, Keiko Furukawa, Koichi Furukawa. Roles of GalNAc-disialyl Lactotetraosyl Antigens in Renal Cancer Cells. Scientific reports. 2020. 10. 1. 6416-6416
Masayoshi Yamane, Jun-Ichi Sawada, Naohisa Ogo, Mai Ohba, Takayuki Ando, Akira Asai. Identification of benzo[d]pyrrolo[2,1-b]thiazole derivatives as CENP-E inhibitors. Biochemical and biophysical research communications. 2019. 519. 3. 505-511
Tadashi Ashizawa, Akira Iizuka, Emiko Tanaka, Ryota Kondou, Haruo Miyata, Chie Maeda, Takashi Sugino, Ken Yamaguchi, Takayuki Ando, Yoshinobu Ishikawa, et al. Antitumor activity of the PD-1/PD-L1 binding inhibitor BMS-202 in the humanized MHC-double knockout NOG mouse. BIOMEDICAL RESEARCH-TOKYO. 2019. 40. 6. 243-250

ｍore...

MISC (36)：

村田等, 安藤隆幸, 安井優, 越智俊樹, 友信奈保子, 山本健一, 木下理恵, 阪口政清. Development of inhibitors of axonal degeneration-inducing molecule SARM1 using human iPS cell-derived neurons and animal models. 組織培養研究(Web). 2023. 41. 2
安藤隆幸, 工藤晃大, 堀池あずさ, 香崎正宙. Drug Discovery of Inhibitor Repaired DNA Damage in Cancer Cells~Start of Crowdfunding Research~. 静岡県環境衛生科学研究所報告(Web). 2023. 65
安藤隆幸. 免疫の抑制を解除する化合物の探索~静岡発の抗がん剤へのチャレンジ~. 静岡県環境衛生科学研究所環衛レポート(Web). 2023. 74
菊地康文, 飯塚明, 芦澤忠, 安藤隆幸, 山口建, 秋山靖人. Identification of unknown target proteins of small molecule compounds by using nanomagnetic beads. 日本癌学会学術総会抄録集(Web). 2023. 82nd
安藤隆幸, 工藤晃大, 石川吉伸, 福田達也, 飯塚明, 芦澤忠, 秋山靖人. 静岡発の抗がん剤への挑戦~低分子化合物は,抗体の代用となれるのか~. 静岡県環境衛生科学研究所業務研究発表会抄録集(Web). 2023. 2023

ｍore...

Patents (8)：

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page